Status:
COMPLETED
The Clinical Outcome of TVM or LSC Mesh Suspension for POP
Lead Sponsor:
Kaohsiung Medical University Chung-Ho Memorial Hospital
Conditions:
Pelvic Organ Prolapse
Eligibility:
FEMALE
20-85 years
Brief Summary
The investigators aim to assess the surgical outcomes of transvaginal mesh (TVM) and laparoscopic (LSC) mesh suspension. During the study period, all women with main uterine prolapse stage II or great...
Detailed Description
All women with mainly uterine prolapse stage II or greater as defined by the POP-Q staging system receiving TVM or LSC mesh suspension surgeries at a tertiary referral center in Taiwan were included. ...
Eligibility Criteria
Inclusion
- Women with mainly uterine prolapse stage II or greater as defined by the POP-Q staging system
Exclusion
- A hypertrophic uterus, huge fibroids
- History of cervical dysplasia or endometrial pathology
- History of postmenopausal bleeding in the past 12 months
- Unwilling to preserve their uterus
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
466 Patients enrolled
Trial Details
Trial ID
NCT04139083
Start Date
January 1 2012
End Date
December 31 2018
Last Update
October 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 807